Transfection with fragments of the adenovirus 12 gene induces tumorigenicity-associated alteration of N-linked sugar chains in rat cells

doi:10.1016/0003-9861(90)90511-V

Archives of Biochemistry and Biophysics

Volume 280, Issue 1, July 1990, Pages 9-19

https://doi.org/10.1016/0003-9861(90)90511-V Get rights and content

Abstract

N-linked sugar chains of rat 3Y1 cells and their poorly tumorigenic (E1Y cells) and highly tumorigenic (CY1 cells) transformants carrying various adenovirus 12 gene fragments were quantitatively released as oligosaccharides from their membrane preparations by hydrazinolysis. After being fractionated by a series of immobilized lectin column chromatography, structures of oligosaccharides in each fraction were studied by sequential glycosidase digestion in combination with methylation analysis. All cells contain bi-, tri-, and tetraantennary complex-type oligosaccharides as well as high mannose-type oligosaccharides in different molar ratio. Expression of 2,4-branched triantennary oligosaccharides increased in both transformed cells. However, their contents were rather higher in poorly tumorigenic E1Y cells than in highly tumorigenic CY1 cells. In contrast, the increase of 2,6-branched triantennary and tetraantennary oligosaccharides was positively correlated to the tumorigenic potential of the transformed cells. The data indicate that glycosylation of cellular proteins is differently affected by the expression of specific regions of the adenovirus genome, and the combined action of E1 and E4 gene products is important for the expression of the GlcNAcβ1→ 6Man group associated with tumorigenicity of the cells.

References (40)

L. Warren et al.
Biochim. Biophys. Acta
(1978)
K. Yamashita et al.
J. Biol. Chem
(1984)
K. Yamashita et al.
J. Biol. Chem
(1985)
M. Pierce et al.
J. Biol. Chem
(1986)
K. Shiroki et al.
Virology
(1977)
K. Shiroki et al.
Virology
(1979)
R. Bernards et al.
Biochim. Biophys. Acta
(1984)
Y.-T. Li et al.
L.R. Glasgow et al.
J. Biol. Chem
(1977)
A. Kobata et al.

M. Kitamikado et al.

Y. Uchida et al.

Biochim. Biophys. Acta

(1974)

J.C. Paulson et al.

J. Biol. Chem

(1982)

J. Amano et al.

J. Biol. Chem

(1988)

K. Yamashita et al.

J. Biol. Chem

(1983)

R.D. Cummings et al.

J. Biol. Chem

(1982)

K. Yamashita et al.

J. Biol. Chem

(1985)

K. Yamashita et al.

J. Biol. Chem

(1987)

K. Yamashita et al.

T. Ohkura et al.

Arch. Biochem. Biophys

(1984)

Cited by (14)

Transcriptional regulation of the human β-1,4-galactosyltransferase V gene in cancer cells. Essential role of transcription factor Sp1
2004, Journal of Biological Chemistry
β-1,4-Galactosyltransferase (β-1,4-GalT) V is a constitutively expressed enzyme that can effectively galactosylate the GlcNAcβ1→6Man group of the highly branched N-glycans that are characteristic of tumor cells. Upon malignant transformation of cells, the expression of the β-1,4-GalT V gene increases in accordance with the increase in the amounts of highly branched N-glycans. Lectin blot analysis showed that the galactosylation of highly branched N-glycans is inhibited significantly in SH-SY5Y human neuroblastoma cells by the transfection of the antisense β-1,4-GalT V cDNA, indicating the biological importance of the β-1,4-GalT V for the functions of highly branched N-glycans. We cloned the 2.3-kb 5′-flanking region of the human β-1,4-GalT V gene, and we identified the region –116/–18 relative to the transcription start site as that having promoter activity. The region was found to contain several putative binding sites for transcription factors, including AP2, AP4, N-Myc, Sp1, and upstream stimulatory factor. Electrophoretic mobility shift assay showed that Sp1 binds to nucleotide positions –81/–69 of the promoter region. Mutations induced in the Sp1-binding site showed that the promoter activity of the β-1,4-GalT V gene is impaired completely in cancer cells. In contrast, the promoter activity increased significantly by the transfection of the Sp1 cDNA into A549 human lung carcinoma cells. Mithramycin A, which inhibits the binding of Sp1 to its binding site, reduced the promoter activation and expression of the β-1,4-GalT V gene in A549 cells. These results indicate that Sp1 plays an essential role in the transcriptional activity of the β-1,4-GalT V gene in cancer cells.
cDNA cloning and expression of bovine UDP-N-acetylglucosamine: α1,3-D- mannoside β1,4-N-acetylglucosaminyltransferase IV
1998, Journal of Biological Chemistry
UDP-N-acetylglucosamine:α1,3-d-mannoside β1,4-N-acetylglucosaminyltransferase (GnT-IV) is one of the essential enzymes in the production of tri- and tetra-antennary Asn-linked sugar chains. Recently, we have successfully purified GnT-IV from bovine small intestine. Based on the partial amino acid sequence of the purified bovine GnT-IV enzyme, its cDNA has been cloned from bovine small intestine. The open reading frame is 1,605 base pairs long, and this sequence produced GnT-IV activity on transient expression in COS-7 cells. Although the deduced amino acid sequence does not have any significant homology with other knownN-acetylglucosaminyltransferases (GnTs), the hydrophobicity profile showed a typical type II transmembrane protein structure, which is common to many glycosyltransferases. N-terminal amino acid sequencing of the purified GnT-IV revealed that 92 amino acids, including a transmembrane region, were truncated during purification. Of the three potential N-glycosylation sites Asn-458 was actually glycosylated in the purified enzyme, although thisN-glycosylation site could be abolished without any reduction in GnT-IV activity. Serial deletions at both the N and C termini proved that the catalytic domain of GnT-IV is located in the central region of the enzyme. The GnT-IV mRNA level correlated with enzymatic activity in the various bovine tissues tested.
Chapter 3c Cancer cells and metastasis. The Warren-Glick phenomenon - a molecular basis of tumorigenesis and metastasis
1996, New Comprehensive Biochemistry
This chapter discusses a molecular basis of tumorigenesis and metastasis of the Warren-Glick phenomenon. The Warren-Glick phenomenon was better observed when radioactive fucose was used for metabolic labeling of glycoproteins. The phenomenon was observed not only in virus-transformed cells but also in chemically and spontaneously transformed cells. Because the chick embryo cells transformed by a temperature-sensitive mutant of Rous sarcoma virus (RSV) produce the large glycopeptides at the permissive temperature but not at the non-permissive temperature, the phenomenon was considered to be an expression of true transformed phenotype. It was also confirmed that the phenomenon is detected in neoplastic epithelial cell lines but not in those of mesenchymal origin. Extensive analyses is presented in the chapter to elucidate the molecular basis of the difference found in the elution profiles of glycopeptides obtained from normal and malignant cells.
Effects of N-3554S, a polyprenyl phosphate, on B16-F10 mouse melanoma cells
1995, BBA - Molecular Cell Research
N-3554S, an optically active S-isomer of α-dihydrodecaprenyl phosphate, reduced the tumorigenicity of cultured B16-F10 mouse melanoma cells probably by affecting protein N-glycosylation. Accordingly, membrane glycoprotein samples were prepared from the melanoma cells cultured with or without N-3554S, and amounts and structures of N-linked sugar chains were determined. Analyses of the N-linked oligosaccharides released by hydrazinolysis from these samples and reduced with NaB³H₄ revealed that the N-3554S-treated cells contain 1.5–1.8 times as much oligosaccharides as the control cells, and the relative amounts of high-mannose-type and bi-, tri- and tetra-antennary complex-type sugar chains are almost the same between two samples. Western blot analysis, however, showed that binding of L-PHA, which binds to oligosaccharides with the GlcNAcβ1 → 6(GlcNAcβ1 → 2)Man structure, is significantly reduced in 90 K, 96 K, 140 K, 155 K and 180 K glycoproteins in N-3554S-treated cells. Immunoblot analysis showed that the 140 K glycoprotein could be a fibronectin receptor. It was also shown that N-3554S treatment enhances the adhesiveness of the cells to fibronectin. These results indicate that N-3554S affects N-glycosylation of membrane glycoproteins and alters the cell surface properties of B16-F10 cells.
Oncogenes and expression of endogenous lectins and glycoconjugates
1993, Biology of the Cell
It is now well established that malignant transformation of eucaryotic cells is concomitant with typical alterations of glycosylation and the expression pattern of endogenous lectins. In parallel, oncogene transfection studies revealed a correlation between the expression of some of these genes, the transformed state and perhaps metastasis. These observations lead to the idea that oncogenes may control the expression of enzymes involved in the biosynthetic pathway of cell membrane glycoconjugates and the expression of endogenous lectins. Indeed, several contributions have shown that cells upon transfection with activated oncogenes of the ras family become invasive and/or metastatic and have their membrane glycoproteins modified. Information on the molecular mechanism of this postulated oncogene regulation is still lacking. Because of the diversity of the functions of oncogene-encoded proteins, further experiments dealing with other activated oncogenes may help in deciphering the regulation of expression of glycoconjugates and endogenous lectins together with their functions.
A novel second isoenzyme of the human UDP-N-acetylglucosamine:α1,3-D-mannoside β1,4-N-acetylglucosaminyltransferase family: cDNA cloning, expression, and chromosomal assignment
1998, Glycoconjugate Journal

View all citing articles on Scopus

^☆: This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (Cancer-Bioscience) from the Ministry of Education, Science and Culture of Japan.

View full text

Transfection with fragments of the adenovirus 12 gene induces tumorigenicity-associated alteration of N-linked sugar chains in rat cells☆

Abstract

Biochim. Biophys. Acta

J. Biol. Chem

J. Biol. Chem

J. Biol. Chem

Virology

Virology

Biochim. Biophys. Acta

J. Biol. Chem

Biochim. Biophys. Acta

J. Biol. Chem

J. Biol. Chem

J. Biol. Chem

J. Biol. Chem

J. Biol. Chem

J. Biol. Chem

Arch. Biochem. Biophys